These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
777 related articles for article (PubMed ID: 24511016)
1. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer. Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016 [TBL] [Abstract][Full Text] [Related]
2. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer. Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT. Wang Y; Ma S; Dong M; Yao Y; Liu K; Zhou J BMC Pulm Med; 2015 Mar; 15():20. PubMed ID: 25880540 [TBL] [Abstract][Full Text] [Related]
6. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma? Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592 [TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550 [TBL] [Abstract][Full Text] [Related]
8. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases. Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018 [TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Kaseda K; Asakura K; Kazama A; Ozawa Y World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499 [TBL] [Abstract][Full Text] [Related]
11. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. Park SY; Yoon JK; Park KJ; Lee SJ Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918 [TBL] [Abstract][Full Text] [Related]
12. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET. Nambu A; Kato S; Sato Y; Okuwaki H; Nishikawa K; Saito A; Matsumoto K; Ichikawa T; Araki T Ann Nucl Med; 2009 May; 23(3):269-75. PubMed ID: 19340527 [TBL] [Abstract][Full Text] [Related]
13. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer. Li M; Liu N; Hu M; Shi F; Yuan S; Zhang P; Fu Z; Yang G; Yu J Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284 [TBL] [Abstract][Full Text] [Related]
14. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of 18-FDG uptake in early stage NSCLC. Chen JC; Huang TW; Cheng YL; Chang H; Tzao C; Huang WS; Lee SC Thorac Cardiovasc Surg; 2009 Oct; 57(7):413-6. PubMed ID: 19795329 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106 [TBL] [Abstract][Full Text] [Related]
17. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer. Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):79-82. PubMed ID: 19366724 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
20. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]